{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:47:30Z","timestamp":1782928050326,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"}],"funder":[{"DOI":"10.13039\/501100012681","name":"Universit\u00e4tsklinikum K\u00f6ln","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012681","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herzschr Elektrophys"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n                  <jats:p>Das aktualisierte Positionspapier der DGK zur Katheterablation von Vorhofflimmern (AF) [1] stellt die aktuelle Evidenz, Techniken und Qualit\u00e4tsstandards dar, die sich seit 2017 gemeinsam mit Indikation, Technik und Rolle der Ablation in der Therapie deutlich gewandelt haben. Die Pulmonalvenenisolation (PVI) bleibt zentraler Bestandteil der AF-Ablation. Neben etablierten Verfahren wie Radiofrequenz- und Kryoablation gewinnt die Pulsed-Field-Ablation (PFA) an Bedeutung. Bei persistierendem AF fehlen klare Empfehlungen \u00fcber die PVI hinaus, trotz zunehmender Daten f\u00fcr erg\u00e4nzende Ablationsstrategien. Die Versorgungssituation zeigt eine starke Zunahme der Ablationen, wobei die tagesgleiche Entlassung nur f\u00fcr selektierte Patienten empfohlen wird. Die pr\u00e4zise Patientenselektion, inklusive Anamnese, Risikofaktoren und Bildgebung sind entscheidend f\u00fcr den Erfolg und die Sicherheit. Die Bedeutung von periprozeduralem Management und strukturierter Nachsorge wird hervorgehoben. Komplikationen wie Perikardtamponade, Schlaganfall und Phrenikusparese erfordern strukturierte Abl\u00e4ufe und erfahrene Teams. Besonders bei Patienten mit Herzinsuffizienz zeigt sich die Ablation als potenziell prognoseverbessernd. Die Zertifizierung von Zentren durch die DGK dient der Qualit\u00e4tssicherung. Neue Entwicklungen wie KI-gest\u00fctzte Ablationsplanung und Studien zur OAK-Strategie nach Ablation werden die Praxis weiter ver\u00e4ndern.<\/jats:p>","DOI":"10.1007\/s00399-026-01149-2","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:53:12Z","timestamp":1779191592000},"page":"229-238","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["DGK Positionspapier\u00a0\u2013\u00a0Qualit\u00e4tssicherung zur Durchf\u00fchrung der Katheterablation von Vorhofflimmern: Executive Summary","Position paper of the German Society of Cardiology\u2014quality criteria for performing catheter ablation of atrial fibrillation: executive summary"],"prefix":"10.1007","volume":"37","author":[{"given":"Daniel","family":"Steven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Deisenhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Deneke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Papathanasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rillig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura M.","family":"Zylla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Veltmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Kommission f\u00fcr Klinische Kardiovaskul\u00e4re Medizin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"1149_CR1","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s12181-025-00774-4","volume":"19","author":"D Steven","year":"2025","unstructured":"Steven\u00a0D, Chun\u00a0J, Deisenhofer\u00a0I et\u00a0al (2025) Qualit\u00e4tskriterien zur Durchf\u00fchrung der Katheterablation von Vorhofflimmern \u2013 DGK-Positionspapier. Kardiologie 19:440\u2013454. https:\/\/doi.org\/10.1007\/s12181-025-00774-4","journal-title":"Kardiologie"},{"key":"1149_CR2","unstructured":"Eckardt, L. & Willems, S. S3-Leitlinie Vorhofflimmern. (2025)."},{"key":"1149_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s12181-017-0146-0","volume":"11","author":"K Kuck","year":"2017","unstructured":"Kuck\u00a0K et\u00a0al (2017) Qualit\u00e4tskriterien zur Durchf\u00fchrung der Katheterablation von Vorhofflimmern. Der Kardiologe 11:161\u2013182","journal-title":"Der Kardiologe"},{"key":"1149_CR4","unstructured":"AOK Rheinland\/Hamburg (2024) Gesundheitsreport 2024 AOK."},{"key":"1149_CR5","unstructured":"Deutscher Herzbericht 2024. (2024)."},{"key":"1149_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euae200","volume":"26","author":"MM Zylla","year":"2024","unstructured":"Zylla\u00a0MM et\u00a0al (2024) Same-day discharge vs. overnight stay following catheter ablation for atrial fibrillation: a comprehensive review and meta-analysis by the European Heart Rhythm Association Health Economics Committee. Europace 26:euae200","journal-title":"Europace"},{"key":"1149_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s12181-023-00602-7","volume":"17","author":"C Stellbrink","year":"2023","unstructured":"Stellbrink\u00a0C et\u00a0al (2023) Strukturelle, prozedurale und personelle Voraussetzungen f\u00fcr eine ambulante bzw. station\u00e4re Erbringung kardiologischer Leistungen: Structural, procedural and personnel prerequisites for outpatient vs. inhospital provision of cardiological services. Die Kardiologie 17:95\u2013110","journal-title":"Die Kardiologie"},{"key":"1149_CR8","unstructured":"Van Gelder, I. C. et\u00a0al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J ehae176 (2024)."},{"key":"1149_CR9","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.jacep.2024.12.018","volume":"11","author":"J Wolfes","year":"2025","unstructured":"Wolfes\u00a0J, Ellermann\u00a0C, Frommeyer\u00a0G, Eckardt\u00a0L (2025) Comparison of the Latest ESC, ACC\/AHA\/ACCP\/HRS, and CCS Guidelines on the Management of Atrial Fibrillation. JACC Clin Electrophysiol 11:836\u2013849","journal-title":"JACC Clin Electrophysiol"},{"key":"1149_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1707855","volume":"378","author":"NF Marrouche","year":"2018","unstructured":"Marrouche\u00a0NF et\u00a0al (2018) Catheter Ablation for Atrial Fibrillation with Heart Failure. N\u00a0Engl J Med 378:417\u2013427","journal-title":"N Engl J Med"},{"key":"1149_CR11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.120.008461","volume":"13","author":"C Sohns","year":"2020","unstructured":"Sohns\u00a0C et\u00a0al (2020) Impact of Left Ventricular Function and Heart Failure Symptoms on Outcomes Post Ablation of Atrial Fibrillation in Heart Failure: CASTLE-AF Trial. Circ Arrhythm Electrophysiol 13:e008461","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1149_CR12","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/europace\/euaa298","volume":"23","author":"KH Kuck","year":"2021","unstructured":"Kuck\u00a0KH et\u00a0al (2021) Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST). EP Europace 23:362\u2013369","journal-title":"EP Europace"},{"key":"1149_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.tcm.2025.08.004","volume":"36","author":"N Alhourani","year":"2026","unstructured":"Alhourani\u00a0N, Ellermann\u00a0C, Wolfes\u00a0J, Meyer\u00a0C, Eckardt\u00a0L (2026) Analysis of randomized controlled studies comparing ablation with antiarrhythmic drugs. Trends Cardiovasc Med 36:76\u201381","journal-title":"Trends Cardiovasc Med"},{"key":"1149_CR14","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa1602014","volume":"374","author":"KH Kuck","year":"2016","unstructured":"Kuck\u00a0KH et\u00a0al (2016) Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation. N\u00a0Engl J Med 374:2235\u20132245","journal-title":"N Engl J Med"},{"key":"1149_CR15","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1056\/NEJMoa2307291","volume":"389","author":"VY Reddy","year":"2023","unstructured":"Reddy\u00a0VY et\u00a0al (2023) Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation. N\u00a0Engl J Med 389:1660\u20131671","journal-title":"N Engl J Med"},{"key":"1149_CR16","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1038\/s41591-024-03114-3","volume":"30","author":"E Ekanem","year":"2024","unstructured":"Ekanem\u00a0E et\u00a0al (2024) Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study. Nat Med 30:2020\u20132029","journal-title":"Nat Med"},{"key":"1149_CR17","doi-asserted-by":"crossref","unstructured":"Tzeis, S.\u00a0et\u00a0al. 2024 European Heart Rhythm Association\/Heart Rhythm Society\/Asia Pacific Heart Rhythm Society\/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation. J\u00a0Interv Card Electrophysiol (2024).","DOI":"10.1016\/j.hrthm.2024.03.017"},{"key":"1149_CR18","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1161\/CIRCULATIONAHA.110.946806","volume":"122","author":"F Ouyang","year":"2010","unstructured":"Ouyang\u00a0F et\u00a0al (2010) Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5\u2011year follow-up. Circulation 122:2368\u20132377","journal-title":"Circulation"},{"key":"1149_CR19","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00399-021-00794-z","volume":"32","author":"L Iden","year":"2021","unstructured":"Iden\u00a0L et\u00a0al (2021) Pulmonary vein isolation using radiofrequency ablation. Herzschrittmacherther Elektrophysiol 32:395\u2013405","journal-title":"Herzschrittmacherther Elektrophysiol"},{"key":"1149_CR20","first-page":"775","volume":"19","author":"M Das","year":"2017","unstructured":"Das\u00a0M et\u00a0al (2017) Ablation index, a novel marker of ablation lesion quality: prediction of pulmonary vein reconnection at repeat electrophysiology study and regional differences in target values. Europace 19:775\u2013783","journal-title":"Europace"},{"key":"1149_CR21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.122.011780","volume":"16","author":"M Duytschaever","year":"2023","unstructured":"Duytschaever\u00a0M et\u00a0al (2023) Paroxysmal Atrial Fibrillation Ablation Using a Novel Variable-Loop Biphasic Pulsed Field Ablation Catheter Integrated With a 3\u2011Dimensional Mapping System: 1\u2011Year Outcomes of the Multicenter inspIRE Study. Circ Arrhythm Electrophysiol 16:e011780","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1149_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euaf066","volume":"27","author":"A Sultan","year":"2025","unstructured":"Sultan\u00a0A et\u00a0al (2025) HIgh Power short duration radiofrequency ablation or cryoballoon ablation for paroxysmal Atrial Fibrillation (HIPAF trial). Europace 27:euaf066","journal-title":"Europace"},{"key":"1149_CR23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa2029980","volume":"384","author":"JG Andrade","year":"2021","unstructured":"Andrade\u00a0JG et\u00a0al (2021) Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation. N\u00a0Engl J Med 384:305\u2013315","journal-title":"N Engl J Med"},{"key":"1149_CR24","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.021323","volume":"10","author":"R Rordorf","year":"2021","unstructured":"Rordorf\u00a0R et\u00a0al (2021) Cryoballoon Ablation for the Treatment of Atrial Fibrillation in Patients With Concomitant Heart Failure and Either Reduced or Preserved Left Ventricular Ejection Fraction: Results From the Cryo AF Global Registry. J\u00a0Am Heart Assoc 10:e021323","journal-title":"J Am Heart Assoc"},{"key":"1149_CR25","doi-asserted-by":"crossref","unstructured":"Reichlin, T. et\u00a0al. Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation. N Engl J Med (2025).","DOI":"10.1056\/NEJMoa2502280"},{"key":"1149_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13113113","volume":"13","author":"L Katov","year":"2024","unstructured":"Katov\u00a0L, Teumer\u00a0Y, Bothner\u00a0C, Rottbauer\u00a0W, Weinmann-Emhardt\u00a0K (2024) Pulmonary Vein Isolation with Pulsed Field Ablation and Size-Adjustable Cryo-Balloon: A Comparative Procedural Analysis of First-Time Use. J\u00a0Clin Med 13:3113","journal-title":"J Clin Med"},{"key":"1149_CR27","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.124.012814","volume":"17","author":"H Nakagawa","year":"2024","unstructured":"Nakagawa\u00a0H et\u00a0al (2024) Evaluation of Ablation Parameters to Predict Irreversible Lesion Size During Pulsed Field Ablation. Circ Arrhythm Electrophysiol 17:e012814","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1149_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12196304","volume":"12","author":"MA Gunawardene","year":"2023","unstructured":"Gunawardene\u00a0MA et\u00a0al (2023) Left Atrial Posterior Wall Isolation with Pulsed Field Ablation in Persistent Atrial Fibrillation. J\u00a0Clin Med 12:6304","journal-title":"J Clin Med"},{"key":"1149_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euaf324","volume":"27","author":"C Meyer","year":"2025","unstructured":"Meyer\u00a0C et\u00a0al (2025) Management of patients with atrial tachycardia: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), and the Association for European Paediatric and Congenital Cardiology (AEPC). Europace 27:euaf324","journal-title":"Europace"},{"key":"1149_CR30","doi-asserted-by":"crossref","unstructured":"Vogler, J. et\u00a0al. Pulmonary Vein Isolation Versus Defragmentation the CHASE-AF Clinical Trial. Journal of the American College of Cardiology 66, (2015).","DOI":"10.1016\/j.jacc.2015.09.088"},{"key":"1149_CR31","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ahj.2017.12.007","volume":"197","author":"A Verma","year":"2018","unstructured":"Verma\u00a0A et\u00a0al (2018) The Optimal Anti-Coagulation for Enhanced-Risk Patients Post-Catheter Ablation for Atrial Fibrillation (OCEAN) trial. Am Heart\u00a0J 197:124\u2013132","journal-title":"Am Heart J"},{"key":"1149_CR32","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.115.019406","volume":"133","author":"L Di Biase","year":"2016","unstructured":"Di Biase\u00a0L et\u00a0al (2016) Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial. Circulation 133:1637\u20131644","journal-title":"Circulation"},{"key":"1149_CR33","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.115.003461","volume":"9","author":"A Rillig","year":"2016","unstructured":"Rillig\u00a0A et\u00a0al (2016) Unexpectedly High Incidence of Stroke and Left Atrial Appendage Thrombus Formation After Electrical Isolation of the Left Atrial Appendage for the Treatment of Atrial Tachyarrhythmias. Circ Arrhythm Electrophysiol 9:e003461","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1149_CR34","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/europace\/euy154","volume":"21","author":"E Str\u00f6ker","year":"2019","unstructured":"Str\u00f6ker\u00a0E et\u00a0al (2019) Value of ultrasound for access guidance and detection of subclinical vascular complications in the setting of atrial fibrillation cryoballoon ablation. Europace 21:434\u2013439","journal-title":"Europace"},{"key":"1149_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euad361","volume":"26","author":"L Eckardt","year":"2023","unstructured":"Eckardt\u00a0L et\u00a0al (2023) Major in-hospital complications after catheter ablation of cardiac arrhythmias: individual case analysis of 43 031 procedures. Europace 26:euad361","journal-title":"Europace"},{"key":"1149_CR36","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1136\/heartjnl-2022-321192","volume":"109","author":"R Mszar","year":"2023","unstructured":"Mszar\u00a0R et\u00a0al (2023) Sex-based differences in atrial fibrillation ablation adverse events. Heart 109:595\u2013605","journal-title":"Heart"},{"key":"1149_CR37","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/europace\/euac215","volume":"25","author":"MA Popa","year":"2023","unstructured":"Popa\u00a0MA et\u00a0al (2023) Safety profile and long-term efficacy of very high-power short-duration (60\u201370\u202fW) catheter ablation for atrial fibrillation: results of a\u00a0large comparative analysis. Europace 25:408\u2013416","journal-title":"Europace"},{"key":"1149_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euad371","volume":"26","author":"S Venier","year":"2023","unstructured":"Venier\u00a0S et\u00a0al (2023) Severe acute kidney injury related to haemolysis after pulsed field ablation for atrial fibrillation. Europace 26:euad371","journal-title":"Europace"},{"key":"1149_CR39","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1016\/j.hrthm.2014.07.039","volume":"11","author":"J Kosiuk","year":"2014","unstructured":"Kosiuk\u00a0J et\u00a0al (2014) Early cerebral thromboembolic complications after radiofrequency catheter ablation of atrial fibrillation: incidence, characteristics, and risk factors. Heart Rhythm 11:1934\u20131940","journal-title":"Heart Rhythm"},{"key":"1149_CR40","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000035518","volume":"102","author":"X Wang","year":"2023","unstructured":"Wang\u00a0X, Li\u00a0M, Wang\u00a0X, Zhang\u00a0Z (2023) It can be safe to discontinue oral anticoagulants after successful atrial fibrillation ablation: A\u00a0systematic review and meta-analysis of cohort studies. Medicine (Baltimore) 102:e35518","journal-title":"Medicine (Baltimore)"},{"key":"1149_CR41","unstructured":"Verma, A. et\u00a0al. Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation. New England Journal of Medicine (2025)."},{"key":"1149_CR42","unstructured":"Wazni, O. M. et\u00a0al. Left Atrial Appendage Closure after Ablation for Atrial Fibrillation. N Engl J Med (2024)."},{"key":"1149_CR43","doi-asserted-by":"crossref","unstructured":"Deisenhofer, I. et\u00a0al. Artificial intelligence for individualized treatment of persistent atrial fibrillation: a\u00a0randomized controlled trial. Nat Med (2025).","DOI":"10.1038\/s41591-025-03517-w"}],"container-title":["Herzschrittmachertherapie + Elektrophysiologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-026-01149-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00399-026-01149-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-026-01149-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:04:57Z","timestamp":1782925497000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00399-026-01149-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1149"],"URL":"https:\/\/doi.org\/10.1007\/s00399-026-01149-2","relation":{},"ISSN":["0938-7412","1435-1544"],"issn-type":[{"value":"0938-7412","type":"print"},{"value":"1435-1544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"23 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Siehe Tab.\u00a0\n                      \n                      im Anhang. D.\u00a0Steven, T.\u00a0Deneke, C.\u00a0Veltmann und L.\u00a0Eckardt sind Mitglieder des Wissenschaftlichen Beirats der Zeitschrift Herzschrittmachertherapie und Elektrophysiologie. Sie waren an der Begutachtung und Entscheidungsfindung zu diesem Manuskript nicht beteiligt.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}